Mr. Wei Fu is an Independent Director at I-Mab, a Chairman at Everest Medicines Ltd., a Chief Executive Officer at Shanghai Kangshiqiao Business Consulting Co. Ltd., a Chief Executive Officer & Managing Partner at C-Bridge Capital Investment Management Ltd. and a Chief Executive Officer at Cbc Group Co. Ltd. He is on the Board of Directors at I-Mab, Ascletis Biopharmaceutical (Hangzhou) Co. Ltd., Everest Medicines (Singapore) Pte Ltd., Everest Medicines II BVI Ltd., Everest Medicines II HK Ltd., Everest Medicines II Ltd., Everonc Medicines Ltd. and Everonc Medicines, Inc. Mr. Fu was previously employed as a General Manager-Investment Department by Far East Horizon Ltd., a Head-Beijing Officer by Themes Investment Management Ltd., an Associate Director-Private Equity Department by Standard Chartered Business Consulting Beijing Co. Ltd., and a Non-Executive Director by Ascletis Pharma, Inc. He received his undergraduate degree from Nanyang Technological University.

Linked companies
CBC Group (Singapore) Pte. Ltd. CBC Group (Singapore) Pte. Ltd. Investment ManagersFinance CBC Group (Singapore) Pte. Ltd.(CBC Group) is a private equity firm founded in 2014 by Wei Fu. The firm is headquartered in Singapore with additional offices in New York, Hong Kong, Shanghai and Beijing and is wholly owned by CBC Group Investment Management Ltd.	Chief Executive Officer
C-Bridge Capital Investment Management Ltd.	Chief Executive Officer